These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33472942)

  • 21. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basics of Epigenetics and Role of Epigenetics in Diabetic Complications.
    Yamunadevi A; Pratibha R; Rajmohan M; Mahendraperumal S; Ganapathy N
    J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S336-S343. PubMed ID: 34447105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetics: deciphering its role in diabetes and its chronic complications.
    Villeneuve LM; Reddy MA; Natarajan R
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):451-9. PubMed ID: 21309809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics of diabetic complications.
    Villeneuve LM; Natarajan R
    Expert Rev Endocrinol Metab; 2010 Jan; 5(1):137-148. PubMed ID: 24077653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture.
    Bornfeldt KE
    Diabetes; 2015 Aug; 64(8):2689-97. PubMed ID: 26207031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Epigenetic Modifications in Late Complications in Type 1 Diabetes.
    Čugalj Kern B; Trebušak Podkrajšek K; Kovač J; Šket R; Jenko Bizjan B; Tesovnik T; Debeljak M; Battelino T; Bratina N
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.
    Syreeni A; El-Osta A; Forsblom C; Sandholm N; Parkkonen M; Tarnow L; Parving HH; McKnight AJ; Maxwell AP; Cooper ME; Groop PH;
    Diabetes; 2011 Nov; 60(11):3073-80. PubMed ID: 21896933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications.
    Rajasekar P; O'Neill CL; Eeles L; Stitt AW; Medina RJ
    J Diabetes Res; 2015; 2015():436879. PubMed ID: 26106624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus.
    Wang J; Xiao M; Wang J; Wang S; Zhang J; Guo Y; Tang Y; Gu J
    Front Endocrinol (Lausanne); 2021; 12():598005. PubMed ID: 34248833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic modification and therapeutic targets of diabetes mellitus.
    Singh R; Chandel S; Dey D; Ghosh A; Roy S; Ravichandiran V; Ghosh D
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32815547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.
    Khullar M; Cheema BS; Raut SK
    Front Endocrinol (Lausanne); 2017; 8():237. PubMed ID: 29085333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.
    Pradhan P; Upadhyay N; Tiwari A; Singh LP
    New Front Ophthalmol; 2016; 2(5):192-204. PubMed ID: 28691104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in epigenetics of acute and chronic kidney diseases.
    Reddy MA; Natarajan R
    Kidney Int; 2015 Aug; 88(2):250-61. PubMed ID: 25993323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic modifications and diabetic retinopathy.
    Kowluru RA; Santos JM; Mishra M
    Biomed Res Int; 2013; 2013():635284. PubMed ID: 24286082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers.
    Kushwaha K; Sharma S; Gupta J
    Biochimie; 2020 Mar; 170():140-151. PubMed ID: 31954720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance.
    Giordo R; Posadino AM; Mangoni AA; Pintus G
    Biochem Pharmacol; 2023 Sep; 215():115732. PubMed ID: 37541452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epigenome in Atherosclerosis.
    Costantino S; Paneni F
    Handb Exp Pharmacol; 2022; 270():511-535. PubMed ID: 33474673
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.